Search Results - "Yin, Min Jean"
-
1
miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3
Published in PloS one (07-11-2013)“…MicroRNAs (miRNAs) have been implicated in the orchestration of diverse cellular processes including differentiation, proliferation, and apoptosis and are…”
Get full text
Journal Article -
2
miR-221 promotes tumorigenesis in human triple negative breast cancer cells
Published in PloS one (24-04-2013)“…Patients with triple-negative breast cancers (TNBCs) typically have a poor prognosis. TNBCs are characterized by their resistance to apoptosis, aggressive…”
Get full text
Journal Article -
3
Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer
Published in European urology (01-07-2014)“…Abstract Background Although prostate cancer responds initially to androgen ablation therapies, progression to castration-resistant prostate cancer (CRPC)…”
Get full text
Journal Article -
4
Clusterin Inhibition Using OGX-011 Synergistically Enhances Hsp90 Inhibitor Activity by Suppressing the Heat Shock Response in Castrate-Resistant Prostate Cancer
Published in Cancer research (Chicago, Ill.) (01-09-2011)“…Small-molecule inhibitors of Hsp90 show promise in the treatment of castrate-resistant prostate cancer (CRPC); however, these inhibitors trigger a heat shock…”
Get full text
Journal Article -
5
A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis
Published in Clinical cancer research (15-04-2011)“…Prostate cancer responds initially to antiandrogen therapies; however, progression to castration-resistant disease frequently occurs. Therefore, there is an…”
Get full text
Journal Article -
6
Linking Nek6 to p53-induced senescence
Published in Cell cycle (Georgetown, Tex.) (01-01-2011)“…Comment on: Jee HJ, et al. Cell Cycle 2010; 9:4703-10…”
Get full text
Journal Article -
7
Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells
Published in PloS one (31-10-2012)“…Binding of IGF to IGF-IR activates PI3K to generate PIP3 which in turn recruits and activates proteins that contain a pleckstrin homology (PH) domain,…”
Get full text
Journal Article -
8
Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90
Published in Clinical cancer research (15-08-2011)“…Triple-negative breast cancer (TNBC) patients have poor prognoses and survival outcomes such that the development of new targeted therapies is in strong…”
Get full text
Journal Article -
9
Targeting the mTOR pathway in tumor malignancy
Published in Current cancer drug targets (01-03-2013)“…The mammalian target of rapamycin (mTOR) plays a critical role in the regulation of cell growth, proliferation,and metabolism by integrating growth factor…”
Get more information
Journal Article -
10
The Serine/Threonine Kinase Nek6 Is Required for Cell Cycle Progression through Mitosis
Published in The Journal of biological chemistry (26-12-2003)“…The Aspergillus nidulans protein NIMA (never in mitosis, gene A) is a protein kinase required for the initiation of mitosis, whereas its inactivation is…”
Get full text
Journal Article -
11
PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity
Published in Molecular cancer therapeutics (01-11-2011)“…Deregulation of the phosphoinositide 3-kinase (PI3K) signaling pathway such as by PTEN loss or PIK3CA mutation occurs frequently in human cancer and…”
Get full text
Journal Article -
12
Discovery of 1‑{(3R,4R)‑3-[({5-Chloro-2-[(1-methyl‑1H‑pyrazol-4-yl)amino]‑7H‑pyrrolo[2,3‑d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
Published in Journal of medicinal chemistry (10-03-2016)“…First generation EGFR TKIs (gefitinib, erlotinib) provide significant clinical benefit for NSCLC cancer patients with oncogenic EGFR mutations. Ultimately,…”
Get full text
Journal Article -
13
Differential Transcriptional Activation by Human T-Cell Leukemia Virus Type 1 Tax Mutants Is Mediated by Distinct Interactions with CREB Binding Protein and p300
Published in Molecular and Cellular Biology (01-04-1998)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
14
Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target
Published in Molecular cancer research (01-05-2010)“…We investigated the role of Nek6, a member of the NIMA-related serine/threonine kinase family, in tumorigenesis. Transcript, protein, and kinase activity…”
Get full text
Journal Article -
15
IκB Kinase α (IKKα) Regulation of IKKβ Kinase Activity
Published in Molecular and Cellular Biology (01-05-2000)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
16
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Published in Nature (London) (05-11-1998)“…NF-κB comprises a family of cellular transcription factors that are involved in the inducible expression of a variety of cellular genes that regulate the…”
Get full text
Journal Article -
17
-
18
Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216
Published in Clinical cancer research (01-02-2014)“…Constitutive activation of phosphoinositide 3-kinase (PI3K) occurs frequently in many human tumors via either gene mutation in the p110α catalytic subunit of…”
Get full text
Journal Article -
19
Sulindac Inhibits Activation of the NF-κB Pathway
Published in The Journal of biological chemistry (17-09-1999)“…Sulindac is a non-steroidal anti-inflammatory agent that is related both structurally and pharmacologically to indomethacin. In addition to its…”
Get full text
Journal Article -
20
Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone
Published in Journal of medicinal chemistry (14-01-2010)“…The discovery and optimization of potency and metabolic stability of a novel class of dihyroxyphenylisoindoline amides as Hsp90 inhibitors are presented…”
Get full text
Journal Article